Cue Biopharma, Inc. Increase (Decrease) in Other Current Assets
Cue Biopharma, Inc. (CUE) reported Increase (Decrease) in Other Current Assets of $184.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2025-08-12
- 2025-06-30: Increase (Decrease) in Other Current Assets 6 month $184.00K.
- 2024-06-30: Increase (Decrease) in Other Current Assets 6 month $0.00.
- 2020-09-30: Increase (Decrease) in Other Current Assets 9 month $250.00K.
| Period end | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month |
|---|---|---|
| 2025-06-30 | $184.00K 10-Q · filed 2025-08-12 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-12 | |
| 2020-09-30 | $250.00K 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |